These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33946414)

  • 41. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells.
    Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M
    J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
    Maartens G; Brill MJE; Pandie M; Svensson EM
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):26-29. PubMed ID: 29145924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
    Elmoghayer ME; Saleh NM; Abu Hashim II
    Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis.
    Shah AA; Shah A; Lewis S; Ghate V; Saklani R; Narayana Kalkura S; Baby C; Singh PK; Nayak Y; Chourasia MK
    Eur J Pharm Biopharm; 2021 Oct; 167():127-139. PubMed ID: 34329710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhalable Andrographolide-β-cyclodextrin Inclusion Complexes for Treatment of Staphylococcus aureus Pneumonia by Regulating Immune Responses.
    Zhang T; Zhu L; Li M; Hu Y; Zhang E; Jiang Q; Han G; Jin Y
    Mol Pharm; 2017 May; 14(5):1718-1725. PubMed ID: 28378587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved solubility and stability of 7-hydroxy-4-methylcoumarin at different temperatures and pH values through complexation with sulfobutyl ether-β-cyclodextrin.
    Liu M; Chen A; Wang Y; Wang C; Wang B; Sun D
    Food Chem; 2015 Feb; 168():270-5. PubMed ID: 25172710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
    Paul S; Heng PW; Chan LW
    J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
    Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria.
    Martin A; Godino IT; Aguilar-Ayala DA; Mathys V; Lounis N; Villalobos HR
    J Med Microbiol; 2019 Aug; 68(8):1137-1139. PubMed ID: 31210631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
    Ren L; Yang X; Guo W; Wang J; Chen G
    Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
    Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
    Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.